Description
CJC-1295 With DAC Peptide Vials
| CJC – 1295 DAC Peptide | |
| CAS number | 863288-34-0 |
| Molar Mass | 3367.954 g·mol−1 |
| Chemical Formula | C152H252N44O42 |
| IUPAC Name | CJC 1295 (DAC-GRF) |
Introduction
CJC-1295 With Dac is a peptide designed exclusively for research purposes. This peptide is of interest to researchers investigating its potential impact on growth hormone release and related factors.
Key Characteristics
CJC-1295 With Dac is known for its extended half-life due to the addition of Drug Affinity Complex (Dac), potentially leading to prolonged effects on growth hormone release.
Research Applications
This research peptide is formulated for scientific investigations aiming to understand the properties and effects of CJC-1295 With Dac. Researchers may explore its applications in various research models.
Research Benefits
CJC-1295 and Growth Hormone
Studies suggest that CJC-1295 With Dac may stimulate the release of growth hormone, which could be of interest to researchers exploring its impact on physiological processes.
CJC-1295 and IGF-1
Research may focus on the potential relationship between CJC-1295 and insulin-like growth factor 1 (IGF-1), as IGF-1 is often associated with growth hormone activity.
CJC-1295 and GH Deficiency
Researchers may investigate whether CJC-1295 With Dac holds promise in addressing growth hormone deficiency, potentially contributing to therapeutic advancements.
Summary
CJC-1295 With Dac is a research peptide designed for scientific exploration into its impact on growth hormone release and related factors. Researchers are encouraged to investigate its applications and potential benefits in various research models.
Disclaimer
This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.
Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).
Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.
Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].
IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.
References
- Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006 Mar;91(3):799-805. doi: 10.1210/jc.2005-1536. Epub 2005 Dec 13. PMID: 16352683. [Read More].
- Clemmons DR. Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency. Horm Res. 2007;68 Suppl 5:178-81. doi: 10.1159/000110620. Epub 2007 Dec 10. PMID: 18174751. [Read More].
Eleanor –
I’ve noticed some improvements in skin tone and overall vitality.